| Traits | Data sources | Sample size (case/control) | Ancestry | Adjustments in the GWAS |
| UC | de Lange et al. | 12,366/33,609 | European | The first ten genetic principal components | CD | de Lange et al. | 12,194/28,072 | European | The first ten genetic principal components | AP | FinnGen | 3,022/195,144 | European | Age, sex, and the first ten genetic principal components | IBS | FinnGen | 4,605/182,423 | European | Age, sex, and the first ten genetic principal components | GERD | Ong et al. | 129,080/473,524 | European | Age, genetic sex, the first ten principal components, and cryptic relatedness | Cholelithiasis | FinnGen | 19,023/195,144 | European | Age, sex, and the first ten genetic principal components | CeD | Trynka et al. | 11,812/11,837 | European | Age, sex, and the first ten genetic principal components | IL-6 | SCALLOP | 21,758 | European | Age and sex | CRP | Ligthart et al. | 204,402 | European | Age, sex, and population substructure | TNF-α | Cardiovascular risk in young finns study and the FINRISK studies | 8293 | European | Age, sex, body mass index, and the first ten genetic principal components |
|
|
UC, ulcerative colitis; CD, Crohn’s disease, AP, acute pancreatitis; IBS, irritable bowel syndrome; GERD, gastroesophageal reflux disease; CeD, celiac disease; IL-6, interleukin 6; CRP, C-reactive protein; TNF-α, tumor necrosis factor-α; SCALLOP, systematic and combined analysis of olink proteins.
|